07-Jun-2012 - in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.
04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
28-May-2012 - West Pharmaceutical Services expects significant growth from biosimilars as manufacturers use novel delivery devices as a “key differentiator”.
15-May-2012 - Codexis posted a jump in pharma sales after the Lipitor patent loss drove an uptick in demand for its atorvastatin intermediate.
07-May-2012 - The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.
21-Mar-2012 - Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).
13-Mar-2012 - Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.
13-Feb-2012 - The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.
06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.
19-Oct-2011 - Hospira says ‘quality actions’ taken to fix problems at key injectable drug manufacturing plant in US reduced its third quarter earnings.
10-Oct-2011 - iBio is expanding use of its green plant technology to biosimilar mAbs after producing rituximab using the system.
06-Oct-2011 - South Korean drugmaker Dong-A and Japan’s Meiji Seika Pharma will build a biosimilars plant in a bid to target the global Ab-based drug market.
26-Sep-2011 - ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.
22-Sep-2011 - Oxford Pharmascience expects the challenges facing biopharm to drive interest in its drug delivery and reformulation technologies.
14-Sep-2011 - Albemarle says it will increase what it charges for generic APIs from next month, citing increasing regulatory and testing costs as the main reasons for the hike.
14-Sep-2011 - Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.
29-Aug-2011 - Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.
02-Aug-2011 - OctoPlus is targeting specialty generics manufacturers it believes can benefit from its controlled release drug delivery technologies.
28-Jul-2011 - MeadWestvaco (MWV) has reported increased market share is driving double-digit growth in sales of medical pumps.
05-Jul-2011 - Merck Serono has received European approval for prefilled pen injectors designed to increase compliance during fertility treatment.
30-Jun-2011 - Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.
27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
09-Jun-2011 - Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.
08-Jun-2011 - Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.
06-Jun-2011 - Pfizer says it is considering a manufacturing-focused partnership with China’s Zhejiang Hisun Pharmaceutical as part of its generic drug business.